This provider's $10.6M in total Medicare payments ranks in the 98th percentile of Independent Diagnostic Testing Facility (IDTF) providers nationally.
Their average markup ratio of 6.85x is significantly above the specialty median of 6.1x.
Medicare payments to this provider grew 326% from 2014 to 2023.
AI-generated analysis based on Medicare payment data.
Notable: Payments increased 52% in 2017
Year-over-year payment surges can indicate changes in practice volume, new services, or billing pattern shifts.
Average per-service amounts submitted by the provider compared to what Medicare actually paid — the gap represents the markup.
| Year | Avg Submitted | Avg Paid | Markup Ratio | Gap per Service | Total Payments | Services | Beneficiaries |
|---|---|---|---|---|---|---|---|
| 2014 | $3.7K | $500.36 | 7.47x | $3.2K | $466.4K | 900 | 736 |
| 2015 | $3.1K | $334.49 | 9.22x | $2.8K | $690.7K | 3.1K | 2.0K |
| 2016 | $3.4K | $504.58 | 6.77x | $2.9K | $967.6K | 3.4K | 2.3K |
| 2017 | $3.4K | $771.69 | 4.36x | $2.6K | $1.5M | 3.7K | 2.6K |
| 2018 | $3.1K | $482.55 | 6.51x | $2.7K | $749.3K | 3.1K | 2.1K |
| 2019 | $2.8K | $416.04 | 6.82x | $2.4K | $887.4K | 3.3K | 2.2K |
| 2020 | $2.6K | $327.51 | 7.98x | $2.3K | $820.8K | 2.9K | 2.0K |
| 2021 | $3.1K | $583.70 | 5.29x | $2.5K | $1.0M | 3.0K | 2.0K |
| 2022 | $3.5K | $777.25 | 4.48x | $2.7K | $1.5M | 3.1K | 2.3K |
| 2023 | $3.0K | $618.07 | 4.92x | $2.4K | $2.0M | 3.5K | 2.7K |
| Code | Description | Services | Payments | Avg/Service | Markup |
|---|---|---|---|---|---|
| 78815 | Nuclear medicine study with CT imaging skull base to mid-thigh | 4.3K | $4.8M | $1.1K | 6.05x |
| A9595 | Piflufolastat f-18, diagnostic, 1 millicurie | 376 | $1.4M | $3.7K | 1.29x |
| 74177 | CT scan of abdomen and pelvis with contrast | 4.8K | $836.5K | $175.88 | 19.08x |
| 78816 | Nuclear medicine study with CT imaging whole body | 675 | $750.9K | $1.1K | 6.89x |
| Q9983 | florbetaben f18 diagnostic | 337 | $735.5K | $2.2K | 1.28x |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 4.5K | $508.7K | $113.08 | 1.35x |
| 78814 | Nuclear medicine study with CT imaging | 453 | $498.3K | $1.1K | 5.92x |
| 71260 | CT scan chest with contrast | 5.6K | $388.4K | $69.05 | 26.26x |
| A9588 | Fluciclovine f-18, diagnostic, 1 millicurie | 148 | $251.1K | $1.7K | 1.41x |
| 78608 | Nuclear medicine study brain with metabolic evaluation | 130 | $135.8K | $1.0K | 6.77x |
| A9586 | Florbetapir f18, diagnostic, per study dose, up to 10 millicuries | 52 | $118.1K | $2.3K | 1.28x |
| 71250 | CT scan chest | 749 | $45.4K | $60.61 | 28.40x |
| 74176 | CT scan of abdomen and pelvis | 488 | $37.2K | $76.22 | 40.18x |
| 74160 | CT scan abdomen with contrast | 244 | $27.0K | $110.78 | 16.39x |
| 70491 | CT scan of neck with contrast | 335 | $22.8K | $68.06 | 19.79x |
| 74178 | CT scan of abdomen and pelvis before and after contrast | 89 | $17.9K | $201.03 | 18.47x |
| 71275 | CT scan of blood vessels in chest with contrast | 58 | $8.2K | $141.59 | 20.42x |
| 70486 | Ct scan of face without contrast | 23 | $1.6K | $71.51 | 12.29x |
| 75571 | Ct scan of heart with evaluation of blood vessel calcium | 29 | $1.5K | $52.05 | 9.18x |
| 71270 | CT scan chest before and after contrast | 12 | $854.36 | $71.20 | 28.01x |
This provider submits charges 6.85 times higher than what Medicare actually pays.
A markup ratio of 6.85x means for every $100 Medicare pays, this provider initially charges $685. This is higher than the national average.
Always verify provider credentials and location before scheduling appointments. This data reflects Medicare payments and may not include all practice locations.
Other Independent Diagnostic Testing Facility (IDTF) providers in TX for peer comparison.
| Provider | Location | Total Payments | Status |
|---|---|---|---|
| Boston Scientific Cardiac Diagnostic Services, Llc | Houston, TX | $454.8M | ⚠️ Flagged |
| Alliance Neurodiagnostics, Llc | Irving, TX | $58.5M | ✓ Clear |
Share this provider's Medicare payment information
Last Updated: February 2026 (data through 2023, the latest CMS release)
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.
Believe this data is inaccurate? Dispute this data